A mix of S and [Delta]S variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture
Activated B-cell-like diffuse large B-cell lymphoma (ABC DLBCL) is characterized by increased expression and activator of signal transducer and activator of transcription 3 (STAT3). ABC DLBCL cells require STAT3 for growth in culture. In ABC DLBCL cells, eosinophils and perhaps all cells, four varia...
Gespeichert in:
Veröffentlicht in: | Oncogenesis (New York, NY) NY), 2016-01, Vol.5, p.e184 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | e184 |
container_title | Oncogenesis (New York, NY) |
container_volume | 5 |
creator | Zheng, M Turton, K B Zhu, F Li, Y Grindle, K M Annis, D S Lu, L Drennan, A C Tweardy, D J Bharadwaj, U Mosher, D F Rui, L |
description | Activated B-cell-like diffuse large B-cell lymphoma (ABC DLBCL) is characterized by increased expression and activator of signal transducer and activator of transcription 3 (STAT3). ABC DLBCL cells require STAT3 for growth in culture. In ABC DLBCL cells, eosinophils and perhaps all cells, four variant STAT3 mRNAs (S, S, S and S) are present as a result of two alternative splicing events, one that results in the inclusion of a 55-residue C-terminal transactivation domain () or a truncated C-terminal domain with 7 unique residues () and a second that includes (S) or excludes (S) the codon for Ser-701 in the linker between the SH2 and C-terminal domains. A substantial literature indicates that both and variants are required for optimal STAT3 function, but nothing is known about functions of S variants. We used a knockdown/re-expression strategy to explore whether survival of ABC DLBCL cells requires that the four variants be in an appropriate ratio. No single variant rescued survival as well as STAT3S-C, S with activating mutations (A661C and N663C) in the SH2 domain. Better rescue was achieved when all four variants were re-expressed or S and S or S and S were re-expressed in pairs. Rescue correlated with expression of STAT3-sensitive genes NFKBIA and NFKBIZ. We consider a variety of explanations why a mix of S and S variants of STAT3 should enable survival of ABC DLBCL cells. |
doi_str_mv | 10.1038/oncsis.2015.44 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1788352834</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4053325341</sourcerecordid><originalsourceid>FETCH-proquest_journals_17883528343</originalsourceid><addsrcrecordid>eNqNyj9PwzAQBXALCYkKunY-iTkhjuM2jOWf2JsNoeqaXMDFsYvPjmDkm5OifgBuee_pd0IsZJHLQtU33rVsOC8LqfOqOhOzUupVdluU1YWYM--L6fRSLrWeiZ81DOYLfA8bQNfBywPZiK8bGDEYdJH_qFk3CsjhzhJwCqMZ0R4B2zjVSB3cZS1Zm1nzQdCZvk9MYDG80UnAfg-Hdz8gHBeDcdAmG1OgK3Heo2Wan_JSXD89NvfP2SH4z0Qct3ufgptoK1d1rXRZq0r97-sX1Q5U1A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1788352834</pqid></control><display><type>article</type><title>A mix of S and [Delta]S variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Zheng, M ; Turton, K B ; Zhu, F ; Li, Y ; Grindle, K M ; Annis, D S ; Lu, L ; Drennan, A C ; Tweardy, D J ; Bharadwaj, U ; Mosher, D F ; Rui, L</creator><creatorcontrib>Zheng, M ; Turton, K B ; Zhu, F ; Li, Y ; Grindle, K M ; Annis, D S ; Lu, L ; Drennan, A C ; Tweardy, D J ; Bharadwaj, U ; Mosher, D F ; Rui, L</creatorcontrib><description>Activated B-cell-like diffuse large B-cell lymphoma (ABC DLBCL) is characterized by increased expression and activator of signal transducer and activator of transcription 3 (STAT3). ABC DLBCL cells require STAT3 for growth in culture. In ABC DLBCL cells, eosinophils and perhaps all cells, four variant STAT3 mRNAs (S, S, S and S) are present as a result of two alternative splicing events, one that results in the inclusion of a 55-residue C-terminal transactivation domain () or a truncated C-terminal domain with 7 unique residues () and a second that includes (S) or excludes (S) the codon for Ser-701 in the linker between the SH2 and C-terminal domains. A substantial literature indicates that both and variants are required for optimal STAT3 function, but nothing is known about functions of S variants. We used a knockdown/re-expression strategy to explore whether survival of ABC DLBCL cells requires that the four variants be in an appropriate ratio. No single variant rescued survival as well as STAT3S-C, S with activating mutations (A661C and N663C) in the SH2 domain. Better rescue was achieved when all four variants were re-expressed or S and S or S and S were re-expressed in pairs. Rescue correlated with expression of STAT3-sensitive genes NFKBIA and NFKBIZ. We consider a variety of explanations why a mix of S and S variants of STAT3 should enable survival of ABC DLBCL cells.</description><identifier>EISSN: 2157-9024</identifier><identifier>DOI: 10.1038/oncsis.2015.44</identifier><language>eng</language><publisher>New York: Nature Publishing Group</publisher><subject>Cellular biology ; Lymphomas</subject><ispartof>Oncogenesis (New York, NY), 2016-01, Vol.5, p.e184</ispartof><rights>Copyright Nature Publishing Group Jan 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Zheng, M</creatorcontrib><creatorcontrib>Turton, K B</creatorcontrib><creatorcontrib>Zhu, F</creatorcontrib><creatorcontrib>Li, Y</creatorcontrib><creatorcontrib>Grindle, K M</creatorcontrib><creatorcontrib>Annis, D S</creatorcontrib><creatorcontrib>Lu, L</creatorcontrib><creatorcontrib>Drennan, A C</creatorcontrib><creatorcontrib>Tweardy, D J</creatorcontrib><creatorcontrib>Bharadwaj, U</creatorcontrib><creatorcontrib>Mosher, D F</creatorcontrib><creatorcontrib>Rui, L</creatorcontrib><title>A mix of S and [Delta]S variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture</title><title>Oncogenesis (New York, NY)</title><description>Activated B-cell-like diffuse large B-cell lymphoma (ABC DLBCL) is characterized by increased expression and activator of signal transducer and activator of transcription 3 (STAT3). ABC DLBCL cells require STAT3 for growth in culture. In ABC DLBCL cells, eosinophils and perhaps all cells, four variant STAT3 mRNAs (S, S, S and S) are present as a result of two alternative splicing events, one that results in the inclusion of a 55-residue C-terminal transactivation domain () or a truncated C-terminal domain with 7 unique residues () and a second that includes (S) or excludes (S) the codon for Ser-701 in the linker between the SH2 and C-terminal domains. A substantial literature indicates that both and variants are required for optimal STAT3 function, but nothing is known about functions of S variants. We used a knockdown/re-expression strategy to explore whether survival of ABC DLBCL cells requires that the four variants be in an appropriate ratio. No single variant rescued survival as well as STAT3S-C, S with activating mutations (A661C and N663C) in the SH2 domain. Better rescue was achieved when all four variants were re-expressed or S and S or S and S were re-expressed in pairs. Rescue correlated with expression of STAT3-sensitive genes NFKBIA and NFKBIZ. We consider a variety of explanations why a mix of S and S variants of STAT3 should enable survival of ABC DLBCL cells.</description><subject>Cellular biology</subject><subject>Lymphomas</subject><issn>2157-9024</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNyj9PwzAQBXALCYkKunY-iTkhjuM2jOWf2JsNoeqaXMDFsYvPjmDkm5OifgBuee_pd0IsZJHLQtU33rVsOC8LqfOqOhOzUupVdluU1YWYM--L6fRSLrWeiZ81DOYLfA8bQNfBywPZiK8bGDEYdJH_qFk3CsjhzhJwCqMZ0R4B2zjVSB3cZS1Zm1nzQdCZvk9MYDG80UnAfg-Hdz8gHBeDcdAmG1OgK3Heo2Wan_JSXD89NvfP2SH4z0Qct3ufgptoK1d1rXRZq0r97-sX1Q5U1A</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Zheng, M</creator><creator>Turton, K B</creator><creator>Zhu, F</creator><creator>Li, Y</creator><creator>Grindle, K M</creator><creator>Annis, D S</creator><creator>Lu, L</creator><creator>Drennan, A C</creator><creator>Tweardy, D J</creator><creator>Bharadwaj, U</creator><creator>Mosher, D F</creator><creator>Rui, L</creator><general>Nature Publishing Group</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20160101</creationdate><title>A mix of S and [Delta]S variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture</title><author>Zheng, M ; Turton, K B ; Zhu, F ; Li, Y ; Grindle, K M ; Annis, D S ; Lu, L ; Drennan, A C ; Tweardy, D J ; Bharadwaj, U ; Mosher, D F ; Rui, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_17883528343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Cellular biology</topic><topic>Lymphomas</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, M</creatorcontrib><creatorcontrib>Turton, K B</creatorcontrib><creatorcontrib>Zhu, F</creatorcontrib><creatorcontrib>Li, Y</creatorcontrib><creatorcontrib>Grindle, K M</creatorcontrib><creatorcontrib>Annis, D S</creatorcontrib><creatorcontrib>Lu, L</creatorcontrib><creatorcontrib>Drennan, A C</creatorcontrib><creatorcontrib>Tweardy, D J</creatorcontrib><creatorcontrib>Bharadwaj, U</creatorcontrib><creatorcontrib>Mosher, D F</creatorcontrib><creatorcontrib>Rui, L</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Oncogenesis (New York, NY)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, M</au><au>Turton, K B</au><au>Zhu, F</au><au>Li, Y</au><au>Grindle, K M</au><au>Annis, D S</au><au>Lu, L</au><au>Drennan, A C</au><au>Tweardy, D J</au><au>Bharadwaj, U</au><au>Mosher, D F</au><au>Rui, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A mix of S and [Delta]S variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture</atitle><jtitle>Oncogenesis (New York, NY)</jtitle><date>2016-01-01</date><risdate>2016</risdate><volume>5</volume><spage>e184</spage><pages>e184-</pages><eissn>2157-9024</eissn><abstract>Activated B-cell-like diffuse large B-cell lymphoma (ABC DLBCL) is characterized by increased expression and activator of signal transducer and activator of transcription 3 (STAT3). ABC DLBCL cells require STAT3 for growth in culture. In ABC DLBCL cells, eosinophils and perhaps all cells, four variant STAT3 mRNAs (S, S, S and S) are present as a result of two alternative splicing events, one that results in the inclusion of a 55-residue C-terminal transactivation domain () or a truncated C-terminal domain with 7 unique residues () and a second that includes (S) or excludes (S) the codon for Ser-701 in the linker between the SH2 and C-terminal domains. A substantial literature indicates that both and variants are required for optimal STAT3 function, but nothing is known about functions of S variants. We used a knockdown/re-expression strategy to explore whether survival of ABC DLBCL cells requires that the four variants be in an appropriate ratio. No single variant rescued survival as well as STAT3S-C, S with activating mutations (A661C and N663C) in the SH2 domain. Better rescue was achieved when all four variants were re-expressed or S and S or S and S were re-expressed in pairs. Rescue correlated with expression of STAT3-sensitive genes NFKBIA and NFKBIZ. We consider a variety of explanations why a mix of S and S variants of STAT3 should enable survival of ABC DLBCL cells.</abstract><cop>New York</cop><pub>Nature Publishing Group</pub><doi>10.1038/oncsis.2015.44</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | EISSN: 2157-9024 |
ispartof | Oncogenesis (New York, NY), 2016-01, Vol.5, p.e184 |
issn | 2157-9024 |
language | eng |
recordid | cdi_proquest_journals_1788352834 |
source | DOAJ Directory of Open Access Journals; PubMed Central Open Access; Springer Nature OA Free Journals; Nature Free; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Cellular biology Lymphomas |
title | A mix of S and [Delta]S variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T09%3A32%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20mix%20of%20S%20and%20%5BDelta%5DS%20variants%20of%20STAT3%20enable%20survival%20of%20activated%20B-cell-like%20diffuse%20large%20B-cell%20lymphoma%20cells%20in%20culture&rft.jtitle=Oncogenesis%20(New%20York,%20NY)&rft.au=Zheng,%20M&rft.date=2016-01-01&rft.volume=5&rft.spage=e184&rft.pages=e184-&rft.eissn=2157-9024&rft_id=info:doi/10.1038/oncsis.2015.44&rft_dat=%3Cproquest%3E4053325341%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1788352834&rft_id=info:pmid/&rfr_iscdi=true |